News Summary

Teal Health, co-founded by Kara Egan and Dr. Avnesh Thakor in 2020, has raised $10 million in a seed extension to develop the Teal Wand, an at-home cervical cancer screening device. The funding round was led by Emerson Collective and Forerunner, with contributions from Serena Ventures, Chelsea Clinton, and Labcorp, bringing total funding to $23 million. The Teal Wand aims to provide a more comfortable alternative to traditional OB/GYN visits, allowing women to collect samples at home and send them to a lab for analysis. The device is pending FDA approval, and the company plans to use the funds to enhance its telehealth platform, educational resources, and customer support tools. This innovation addresses the decline in cervical cancer screening rates by offering a convenient and accessible option for women, especially in areas with limited access to OB/GYN care.